Get the Stockscreener App
19.57
3.08%
0.585
Oculis Holding Ag stock is traded at $19.57, with a volume of 74,124.
It is up +3.08% in the last 24 hours and up +1.58% over the past month.
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
See More
Previous Close:
$18.99
Open:
$18.98
24h Volume:
74,124
Relative Volume:
0.93
Market Cap:
$1.13B
Revenue:
-
Net Income/Loss:
$-75.28M
P/E Ratio:
-9.8086
EPS:
-1.9957
Net Cash Flow:
$-57.45M
1W Performance:
+3.52%
1M Performance:
+1.58%
6M Performance:
+2.22%
1Y Performance:
+25.97%
1-Day Range:
$18.98
$19.84
1-Week Range:
$18.64
$19.84
52-Week Range:
$14.00
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Compare OCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.57 | 1.10B | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Needham | Buy |
| Dec-05-23 | Initiated | Chardan Capital Markets | Buy |
| Oct-05-23 | Initiated | Stifel | Buy |
| Jun-14-23 | Initiated | BofA Securities | Buy |
| Jun-12-23 | Initiated | H.C. Wainwright | Buy |
| Jun-08-23 | Initiated | Robert W. Baird | Outperform |
| May-10-23 | Initiated | Pareto | Buy |
| Apr-28-23 | Initiated | Wedbush | Outperform |
View All
Oculis Holding Ag Stock (OCS) Latest News
Will Oculis Holding AG stock benefit from commodity prices2025 Trading Recap & Risk Controlled Swing Alerts - Newser
Is Oculis Holding’s New Equity Shelf Shaping a More Flexible Capital Strategy for OCS Investors? - simplywall.st
Oculis (NASDAQ:OCS) Coverage Initiated at Lifesci Capital - MarketBeat
How analysts revise price targets for Oculis Holding AG (CR5) stockMarket Movers & Low Drawdown Momentum Ideas - Newser
Why Oculis Holding AG (CR5) stock is upgraded to buyMarket Activity Report & Weekly Chart Analysis and Guides - Newser
How Oculis Holding AG Equity Warrant stock performs in interest rate cycles2025 Winners & Losers & Verified Swing Trading Watchlists - Newser
LifeSci Capital Initiates Coverage of Oculis Holding (OCS) with Outperform Recommendation - Nasdaq
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - MarketScreener
Oculis Holding AG (OCS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Liquidity Mapping Around (OCS) Price Events - news.stocktradersdaily.com
Why Oculis Holding AG stock could benefit from AI revolution2025 Major Catalysts & AI Driven Price Predictions - moha.gov.vn
Oculis (OCS) files transaction notice for director RSU vesting dated Nov. 25, 2025 - Stock Titan
US Market Recap: Can Oculis Holding AG stock deliver surprise earnings beatJuly 2025 Final Week & Reliable Entry Point Trade Alerts - moha.gov.vn
Can Oculis Holding AG stock deliver surprise earnings beat - BỘ NỘI VỤ
Is Oculis Holding AG Equity Warrant stock positioned well for digital economyTrade Entry Report & Smart Swing Trading Techniques - BỘ NỘI VỤ
How strong is Oculis Holding AG stock balance sheetQuarterly Trade Report & Entry Point Confirmation Signals - BỘ NỘI VỤ
Oculis reports Q3 EPS (32c), consensus (41c) - MSN
Oculis (NASDAQ: OCS) to Run Global PIONEER Privosegtor Trials in AON and NAION - Stock Titan
Analysts Set Oculis Holding AG (NASDAQ:OCS) Target Price at $39.80 - Defense World
Cash per share of Oculis Holding AG – FWB:CR5 - TradingView
Why (OCS) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Will Oculis Holding AG stock keep outperforming rivalsTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Why millennials buy Oculis Holding AG (CR5) stockJuly 2025 Outlook & Stock Portfolio Risk Management - newser.com
Is Oculis Holding AG Equity Warrant stock a good choice for value investorsWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Is Oculis Holding AG Equity Warrant stock oversold or undervaluedJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
What dividend safety score for Oculis Holding AG Equity Warrant stockPrice Action & Expert Curated Trade Ideas - newser.com
Exit strategy if you’re trapped in Oculis Holding AG Equity WarrantQuarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com
Will Oculis Holding AG (CR5) stock hit Wall Street targets2025 Growth vs Value & Real-Time Volume Triggers - newser.com
Can Oculis Holding AG stock sustain market leadershipMarket Growth Report & Community Trade Idea Sharing - newser.com
What moving averages say about Oculis Holding AG2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Will Oculis Holding AG stock deliver shareholder valueQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Why Oculis Holding AG Equity Warrant stock remains resilientEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Oculis Holding AG Equity Warrant stock trend outlook and recovery pathMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
Oculis price target raised to $42 from $36 at H.C. Wainwright - MSN
Why analysts raise outlook for Oculis Holding AG (CR5) stockQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Visualizing Oculis Holding AG Equity Warrant stock with heatmapsDividend Hike & AI Driven Stock Reports - newser.com
Why retail investors favor Oculis Holding AG stock2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Can Oculis Holding AG stock deliver strong Q4 earnings2025 Technical Overview & Advanced Technical Analysis Signals - newser.com
Oculis Holding Ag Stock (OCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):